Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of POLR2F mRNA | affects expression | 21346803
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of POLR2F mRNA | affects expression | 16483693
|
D002995 |
Clofibric Acid |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLR2F mRNA | affects cotreatment|affects expression | 17602206
|
D004052 |
Diethylnitrosamine |
[Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of POLR2F mRNA | affects cotreatment|affects expression | 17602206
|
D005419 |
Flavonoids |
Flavonoids results in decreased expression of POLR2F mRNA | decreases expression | 18035473
|
D007657 |
Ketone Bodies |
Ketone Bodies results in increased expression of POLR2F mRNA | increases expression | 16807920
|
D018038 |
Sodium Selenite |
Sodium Selenite results in increased expression of POLR2F mRNA | increases expression | 18175754
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of POLR2F mRNA | decreases expression | 15328365
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of POLR2F mRNA | increases expression | 18796159
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.18 | 15322242 14514962 11752688 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.90 | 18287403 |
MESH:D000236 |
Adenoma |
|
Diethylnitrosamine |
2.98 | 6695378 10737359 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Diethylnitrosamine |
11.21 | 16434500 17620307 19052882 19061943 17162532 18056438 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.21 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.17 | 11748828 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
3.29 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.17 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.91 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Diethylnitrosamine |
1.94 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.94 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.99 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
3.08 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Diethylnitrosamine |
3.08 | 20514400 10737359 17761372 20432363 19394651 16681979 19335982 16830150 10672840 20524982 19208518 18788625 16288022 21159647 17173139 16779866 19539802 18056438 17978847 18665156 3084413 18691550 19519916 16878318 18393292 17162532 3581430 16540662 19171122 18971187 17428255 19822196 16569478 18494052 17055752 16698587 19052882 19383236 18506893 16502159 19919837 16328049 20084675 18785209 20935162 19107877 18210153 18978308 20214788 20727157 17138121 20101231 16807293 11831363 16935385 20007298 19701751 20512989 19418558 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.49 | 16120746 18850075 18670907 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
7.23 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Diethylnitrosamine |
7.23 | 2727394 17174075 21159647 7505956 |
MESH:D018281 |
Cholangiocarcinoma |
|
Diethylnitrosamine |
10.05 | 19052882 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
10.05 | 16835633 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.06 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.19 | 8697196 15668235 12621046 16354765 15340226 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.27 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 15322242 20055451 10048152 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
4.32 | 18551238 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
3.99 | 16285004 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Diethylnitrosamine |
4.38 | 20387270 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
4.38 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
9.49 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Diethylnitrosamine |
9.49 | 19107877 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
9.49 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
9.49 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.93 | 11462148 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.61 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.28 | 18230668 15322242 16714409 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.25 | 10568697 9294722 |
MESH:D004931 |
Esophageal Achalasia |
|
Diethylnitrosamine |
5.49 | 16302075 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.19 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Diethylnitrosamine |
3.43 | 20387270 21071580 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.76 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.25 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.97 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.44 | 11294989 10048152 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.58 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.20 | 16120746 12621046 15340226 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.42 | 16354765 18606429 8697196 15340226 16959395 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.98 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Diethylnitrosamine |
8.98 | 18785209 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
8.98 | 17296493 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
8.98 | 12878042 12200463 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.42 | 14714311 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.58 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
3.18 | 16705839 |
MESH:D008103 |
Liver Cirrhosis |
|
Diethylnitrosamine |
2.94 | 20032147 19638242 18665156 18522880 18407596 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
1.24 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Diethylnitrosamine |
2.15 | 17034775 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
11.37 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Clofibric Acid |
11.37 | 17602206 |
MESH:D008113 |
Liver Neoplasms |
|
Diethylnitrosamine |
11.37 | 21071580 19256749 20434301 20405173 19255062 12771043 15885732 20137499 21167192 18648771 2422723 18644402 20501860 19690152 16942905 12112319 20583210 10737359 2862719 19812893 19073162 20101389 19642983 18754104 20118626 15175105 19996281 20452335 18978307 19426721 19551842 20492335 19090486 9163691 19850985 21278145 21047994 18977376 19294768 19833225 19427195 19254457 19638242 19499222 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
11.37 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
10.62 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Diethylnitrosamine |
10.62 | 18308698 18093689 3124819 18775883 19519916 17942915 18253720 18544905 19004024 18079962 16842330 16267830 19009564 18164116 17174075 19126423 18282651 17854601 9362446 2563599 21159647 19539802 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
10.62 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Diethylnitrosamine |
2.31 | 21163286 6695378 20970405 20512841 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.31 | 19555203 11884234 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.32 | 14737004 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.21 | 12213967 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
4.20 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Diethylnitrosamine |
2.65 | 3581430 9029167 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.49 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Diethylnitrosamine |
3.54 | 20387270 |
MESH:D009461 |
Neurologic Manifestations |
|
Diethylnitrosamine |
5.49 | 20387270 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.66 | 16049721 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Diethylnitrosamine |
2.49 | 16540662 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.62 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.84 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Diethylnitrosamine |
3.77 | 2563599 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.53 | 11896295 11118676 11399792 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.35 | 18760546 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.12 | 18990726 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.69 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.14 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Diethylnitrosamine |
1.76 | 18456281 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.28 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Diethylnitrosamine |
3.16 | 7505956 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
2.37 | 16049721 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.66 | 10091137 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.97 | 12125929 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.62 | 15886252 |